Brain microischemic phenomena in a woman receiving bevacizumab treatment: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-1947
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Brain microischemic phenomena in a woman receiving bevacizumab treatment: a case report ; volume:5 ; number:1 ; day:27 ; month:2 ; year:2011 ; pages:1-5 ; date:12.2011
Journal of medical case reports ; 5, Heft 1 (27.2.2011), 1-5, 12.2011
- Urheber
-
Quattrocchi, Carlo C.
- Beteiligte Personen und Organisationen
-
Alexandre, Andrea M.
Tonini, Giuseppe
Errante, Yuri
Grasso, Rosario F.
Zobel, Bruno Beomonte
SpringerLink (Online service)
- DOI
-
10.1186/1752-1947-5-84
- URN
-
urn:nbn:de:1111-2016071017704
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Quattrocchi, Carlo C.
- Alexandre, Andrea M.
- Tonini, Giuseppe
- Errante, Yuri
- Grasso, Rosario F.
- Zobel, Bruno Beomonte
- SpringerLink (Online service)
Ähnliche Objekte (12)
Bevacizumab improved prognosis for advanced EGFR-mutant lung adenocarcinoma with brain metastasis receiving cerebral radiotherapy
Periodontal disease in a patient receiving Bevacizumab: a case report
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Synchronization phenomena in the human epileptic brain
Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues
Predicting prognosis for epithelial ovarian cancer patients receiving bevacizumab treatment with CT-based deep learning
Severe hematuria in a patient receiving bevacizumab and pembrolizumab for metastatic cervical cancer: a case report
A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab
A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab
Bevacizumab improved prognosis for advanced EGFR-mutant lung adenocarcinoma with brain metastasis receiving cerebral radiotherapy
Periodontal disease in a patient receiving Bevacizumab: a case report
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Synchronization phenomena in the human epileptic brain
Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues
Predicting prognosis for epithelial ovarian cancer patients receiving bevacizumab treatment with CT-based deep learning
Severe hematuria in a patient receiving bevacizumab and pembrolizumab for metastatic cervical cancer: a case report
A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab
A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab
Bevacizumab improved prognosis for advanced EGFR-mutant lung adenocarcinoma with brain metastasis receiving cerebral radiotherapy
Periodontal disease in a patient receiving Bevacizumab: a case report
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Synchronization phenomena in the human epileptic brain
Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues
Predicting prognosis for epithelial ovarian cancer patients receiving bevacizumab treatment with CT-based deep learning
Severe hematuria in a patient receiving bevacizumab and pembrolizumab for metastatic cervical cancer: a case report
A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab